Viridian Therapeutics, Inc.

Rachunek Zysków i Strat


Statystyki
Dywidendy
Rekomendacje
Wyceny
Wskaźniki
Analiza techniczna



Przychody TTM (mln): 0
EBIT TTM (mln): -254
index 0 1 2 3 4 5 6 7 8 9 10 11 12
Rok finansowy 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 4 4 4 3 3 4 8 4 1 3 2 0 0
Przychód Δ r/r 0.0% -2.0% 0.1% -41.2% 31.5% 20.0% 109.5% -46.8% -76.5% 182.2% -40.2% -82.3% -3.8%
Marża brutto 31.0% 42.1% 24.9% 2.6% 23.6% 100.0% 100.0% -635.1% -2595.6% 79.1% 57.4% -321.0% 100.0%
EBIT (mln) -4 -0 -7 -11 -13 -27 -33 -42 -110 -80 -134 -254 -299
EBIT Δ r/r 0.0% -95.1% 3399.8% 62.9% 11.8% 112.1% 24.7% 26.9% 162.9% -27.8% 68.5% 89.5% 17.5%
EBIT (%) -91.4% -4.5% -159.0% -440.8% -374.8% -662.8% -394.5% -941.0% -10512.4% -2690.8% -7579.2% -81035.0% -99018.2%
Koszty finansowe (mln) 2 2 1 0 0 0 1 1 1 0 0 2 3
EBITDA (mln) -3 -0 -7 -11 -9 -26 -32 -41 -40 -79 -129 -235 -266
EBITDA(%) -67.0% -6.9% -157.9% -433.5% -284.2% -652.7% -379.6% -919.9% -3842.5% -2676.0% -7301.8% -74957.0% -88199.7%
Podatek (mln) 3 2 1 0 0 0 1 1 0 0 -4 19 0
Zysk Netto (mln) -7 -2 -8 -11 -13 -27 -33 -42 -111 -79 -125 -238 -270
Zysk netto Δ r/r 0.0% -70.1% 265.3% 43.6% 11.9% 109.2% 23.4% 29.7% 161.6% -28.4% 58.0% 89.5% 13.6%
Zysk netto (%) -163.7% -50.0% -182.6% -446.3% -379.8% -662.3% -390.0% -950.9% -10569.9% -2680.3% -7079.2% -75711.5% -89387.1%
EPS -38.75 -11.48 -52.46 -21.0 -17.57 -20.66 -16.57 -20.31 -31.2 -6.66 -3.91 -5.31 -3.98
EPS (rozwodnione) -38.75 -11.48 -52.46 -21.0 -17.57 -20.66 -16.57 -20.31 -31.2 -6.66 -3.91 -5.31 -3.98
Ilośc akcji (mln) 0 0 0 1 1 1 2 2 4 12 32 45 68
Ważona ilośc akcji (mln) 0 0 0 1 1 1 2 2 4 12 32 45 68
Waluta USD USD USD USD USD USD USD USD USD USD USD USD USD